Skip to main content
. 2018 Mar;59(3):486–493. doi: 10.2967/jnumed.117.191221

FIGURE 1.

FIGURE 1.

PSMA expression in human tumors. (A) FOLH1 gene expression in cell lines extracted from CCLE database, converted into z score, and plotted on the basis of cancer type. Dot plot with line at median value of prostate cancer cell lines is shown. (B) Expression of FOLH1 in different tissue types from TCGA RNA-Seq version 2 data. Dots on top and bottom of box represent outliers. Bars at top and bottom of box represent minimum and maximum expression values of FOLH1 gene, excluding outliers. Box represents 50% of samples. Horizontal bold line inside box is median FOLH1 expression in disease type. CNS = central nervous system; NSCLC = non–small cell lung carcinoma; UADT = upper aerodigestive tract; PRAD = prostate adenocarcinoma; KIRC = kidney renal clear cell carcinoma; LIHC = liver hepatocellular carcinoma; UCEC = uterine corpus endometrial carcinoma; LGG = brain lower-grade glioma; GBM = glioblastoma multiforme; LUSC = lung squamous cell carcinoma; KICH = kidney chromophobe; OV = ovarian carcinoma; BRCA = breast invasive carcinoma; THCA = thyroid carcinoma; HNSC = head and neck squamous cell carcinoma; LUAD = lung adenocarcinoma; SKCM = skin cutaneous melanoma; BLCA = bladder urothelial carcinoma; READ = rectum adenocarcinoma; COAD = colon adenocarcinoma; KIRP = kidney renal papillary cell carcinoma; LAML = acute myeloid leukemia.